Hood River Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Hood River Capital Management LLC

$4.09 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $23,381 - $30,967	-142 Reduced 0.13%	110,556 $18.7 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $17.9 Million - $24.4 Million	-101,611 Reduced 47.86%	110,698 $24 Million
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $3.28 Million - $4.16 Million	-20,350 Reduced 8.75%	212,309 $38.6 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $991,359 - $1.23 Million	5,176 Added 2.28%	232,659 $45.7 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $12.8 Million - $28.7 Million	103,331 Added 83.23%	227,483 $51.2 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $715,581 - $1.09 Million	7,615 Added 6.53%	124,152 $15.7 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $39,658 - $53,080	401 Added 0.35%	116,537 $14.8 Million
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $8,076 - $11,636	-73 Reduced 0.06%	116,136 $15.2 Million
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $462,079 - $574,722	-4,566 Reduced 3.78%	116,209 $14.2 Million
Q2 2021 Aug 13, 2021	SELL	$107.45 - $135.95 $177,399 - $224,453	-1,651 Reduced 1.35%	120,775 $13.8 Million
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $1.14 Million - $1.59 Million	-11,955 Reduced 8.9%	122,426 $14.7 Million
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $149,030 - $216,384	1,981 Added 1.5%	134,381 $13.7 Million
Q3 2020 Nov 16, 2020	SELL	$71.31 - $109.74 $916,832 - $1.41 Million	-12,857 Reduced 8.85%	132,400 $10.2 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $1.14 Million - $2.16 Million	18,414 Added 14.52%	145,257 $16.2 Million
Q1 2020 May 15, 2020	BUY	$60.41 - $115.92 $7.66 Million - $14.7 Million	126,843 New	126,843 $9.13 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.

Account